<!DOCTYPE html>
<html lang="zh">
<head>
    <meta charset="UTF-8">
    <meta name="keywords" content=""/>
    <meta name="description" content="" />
    <meta name="viewport" content="width=device-width, initial-scale=1.0, maximum-scale=1.0, user-scalable=0" />
    <link rel="icon" href="./../../themes/halo_quickstarter/source/images/favicon.ico" type="image/x-icon" />
	<link rel="stylesheet" type="text/css" href="./../../themes/halo_quickstarter/source/plug/css.css">
	<link rel="stylesheet" href="./../../themes/halo_quickstarter/source/css/kico.css"/>
	<link rel="stylesheet" href="./../../themes/halo_quickstarter/source/css/hingle.css"/>
	<link rel="stylesheet" href="https://cdnjs.cloudflare.com/ajax/libs/font-awesome/4.7.0/css/font-awesome.min.css"/>
	<script type="text/javascript" src="./../../themes/halo_quickstarter/source/js/jquery.min.js"></script>
	<script type="text/javascript" src="./../../themes/halo_quickstarter/source/js/js.js"></script>
	<script type="text/javascript" src="./../../themes/halo_quickstarter/source/js/Top.js"></script>
	<script type="text/javascript" src="./../../themes/halo_quickstarter/source/js/time.js"></script>
	<script type="text/javascript" src="./../../themes/halo_quickstarter/source/js/count.js"></script>
	<!--script type="text/javascript" src="//api.html5media.info/1.2.2/html5media.min.js"></script-->
	<script type="text/javascript" id="wow"></script> 
	<script>
		$(function(){
			$(".li5").click(function() {
				$("html,body").animate({scrollTop:0}, 1000);
			});
		})
	</script>
    <meta name="generator" content="Halo 1.5.4"/>
    

    <meta name="referrer" content="never"><title>2022中国进博会|驭势RDN未来,启新中国高血压介入诊疗新格局! 展会快讯</title>
</head>
<!--##单页模块##-->
<body style="background-color: #ffffff">

<!--##pagetop##-->
<div class="header">
	<div class=" juzhong hidden-xs por DingBu" style="background-image:url(./../../upload/images/PcHead.jpg);background-color: #ced3d6;">
	</div>
</div>
<div id="nav-bar" class="clearfix">



	<div class="M-Nav" id="logo"> 
		<a href="#" class="Logo visible-xs"><img src="./../../upload/images/PhoneHead.jpg" alt="2023大湾区工博会- DMP大湾区工业博览会-深圳工博会"></a> 
	</div>
	<a href="javascript:;" class="M-Nav-btn"><div id="ToIndex"></div></a>
	<a href="./../../../../../../.."  class="M-Nav-btn"><div id="ToIndex02"></div></a>
	<div id="nav">
			<ul>
			<li><a href="./../../index.html" target="_self">首页</a>
			</li>
			<li><a href="./../222300ec19a71f842ce9d2551abffa7c####/index.html" target="_self">关于展会</a>
			 <div class='nav-down-list'>
				 <ul>
					<li><a href="./../../s/exhibition-summary/index.html" target="_self">展会介绍</a></li>
					<li><a href="./../../s/exhibition-hall/index.html" target="_self">展馆介绍</a></li>
					<li><a href="./../../s/中部工博会/index.html" target="_self">南昌工博会</a></li>
					<li><a href="./../../s/福州工博会/index.html" target="_self">福州工博会</a></li>
					<li><a href="./../../api/DMP香港工博会2023.pdf" target="_blank">香港工博会</a></li>
					<li><a href="/xt/cn/" target="_blank">展会展期</a></li>
				</ul>
			</div>
			</li>
			<li><a href="./../222300ec19a71f842ce9d2551abffa7c####/index.html" target="_self">参展商</a>
			 <div class='nav-down-list'>
				 <ul>
					<li><a href="./../../categories/brand/index.html" target="_self">品牌榜</a></li>
					<li><a href="https://admin.dwqgbh.cn/nav/guestbook.htm" target="_self">展位申请</a></li>
				</ul>
			</div>
			</li>
			<li><a href="./../../categories/index.html" target="_self">新闻中心</a>
			 <div class='nav-down-list'>
				 <ul>
					<li><a href="./../../categories/message/index.html" target="_self">信息发布</a></li>
					<li><a href="./../../media/index.html" target="_self">媒体聚焦</a></li>
					<li><a href="./../index.html" target="_self">展会快讯</a></li>
					<li><a href="//tech.dwqgbh.cn/news/" target="_self">科技前沿资讯</a></li>
				</ul>
			</div>
			</li>
			<li><a href="./../../s/about/index.html" target="_self">关于我们</a>
			</li>
			<li><a href="./../222300ec19a71f842ce9d2551abffa7c####/index.html" target="_self">联系我们</a>
			 <div class='nav-down-list'>
				 <ul>
					<li><a href="https://admin.dwqgbh.cn/nav/guestbook.htm" target="_self">展位申请</a></li>
					<li><a href="./../../s/individual/index.html" target="_self">观众报名</a></li>
					<li><a href="./../../../../../../.." target="_self">✆137-6147-0961</a></li>
					<li><a href="mailto:1301150027@qq.com" target="_self">1301150027@qq.com</a></li>
				</ul>
			</div>
			</li>
			</ul>
	</div>


</div>
<div class="nav-bar-height visible-xs"></div>


<main>
    <div class="wrap min">
               
    <h2 style="text-align:center">2022中国进博会|驭势RDN未来,启新中国高血压介入诊疗新格局! </h2>
   <p style="text-align:center">严道医声网  2022-11-06</p>
   <article class="post-content">
   
    <section><section powered-by="xiumi.us"><section><section powered-by="xiumi.us"><section><section powered-by="xiumi.us"><section powered-by="xiumi.us"><section><section><section powered-by="xiumi.us"><section><section powered-by="xiumi.us"><section><span><strong><span>合作开新局 创新赢未来</span></strong></span></section><p><span><strong><span>高血压介入诊疗规范化项目拉开帷幕！</span></strong></span></p><section><section powered-by="xiumi.us"><section><section powered-by="xiumi.us"><section><p><img data-backh="327" data-backw="552" data-croporisrc="https://mmbiz.qpic.cn/mmbiz_jpg/hfau27COcrDQOIZ697qSEbroxYo8kZwPwtBs0hq0BM6oC4T5v7riaxmXxlhibntGeFFibNEIxwibwLpgmfc7nkPEPw/0?wx_fmt=jpeg" data-cropx1="0" data-cropx2="1280" data-cropy1="88.1159420289855" data-cropy2="846.3768115942028" data-ratio="0.5925925925925926" data-src="https://mmbiz.qpic.cn/mmbiz_jpg/hfau27COcrDQOIZ697qSEbroxYo8kZwP8AfEStWMoO8F2g0TQgD9T0OeAQziauUAKaK4c8LhD2KFs3EEmibIW4Ag/640?wx_fmt=jpeg" data-type="jpeg" data-w="1080" class="src" src="./../../static/load.gif"/></p><p><span><br/></span></p><section powered-by="xiumi.us"><section powered-by="xiumi.us"><section><section><section powered-by="xiumi.us"><p><span><strong>2022年11月6日，第五届中国国际进口博览会（下文简称“进博会”）</strong></span>举办期间，RDN疗法与中国高血压诊疗变革之间的链接又加深了一分。</p></section></section></section></section></section><section powered-by="xiumi.us"><p><span><strong>——由美敦力公司与心血管健康联盟共同合作的高血压介入诊疗规范化项目拉开帷幕。</strong></span></p></section><p>心血管健康联盟副主席、北京大学第一医院<span><strong>霍勇教授</strong></span>，心血管健康联盟高血压达标中心认证工作委员会主任委员，北京大学人民医院<span><strong>孙宁玲教授</strong></span>、美敦力全球高级副总裁大中华区总裁<span><strong>顾宇韶先生</strong></span>、美敦力大中华区市场准入、供应链与商务运营服务部副总裁<span><strong>邓坚先生</strong></span>、美敦力企业事务及传播副总裁<span><strong>曹珊女士</strong></span>，以及美敦力中国区冠脉及肾动脉交感神经消融业务副总裁<span><strong>陶嘉先生</strong></span>出席了活动。</p></section></section></section></section></section><section data-role="outer" label="edit by 135editor"><section><section><section><section><section><section><section><section><section><section><p>从心血管介入到脑血管介入，医学领域每一类疾病介入疗法的问世都必将掀起一轮学科巨变的浪潮。</p><section><span><strong>如今，高血压介入学科的这轮浪潮正在酝酿中。</strong></span></section><section>肾动脉交感神经消融术 (Renal Denervation, RDN)以一种微创介入的途径，通过能量消融阻断交感神经以实现降压的方式横空出世，迅速成为了高血压的第三种治疗方式，其发展也或将为高血压疾病的介入诊疗格局带来革命性突破。</section><p><span><strong>大潮之下，驭势者赢。</strong></span></p><p>无论是自2021年起海南博鳌超级医院陆续应用美敦力Symplicity Spyral™肾动脉交感神经多极射频消融导管（该产品尚未在中国大陆上市）完成多例RDN手术，还是各大心血管学术大会上高血压论坛的座无虚席，中国医生正在借势赋能，努力成为未来高血压诊疗领域的“驭势者”。</p></section></section></section></section></section></section></section></section></section></section></section></section></section></section></section></section></section></section></section></section><section powered-by="xiumi.us"><section><section powered-by="xiumi.us"><section><section powered-by="xiumi.us"><section><section powered-by="xiumi.us"><p><br/></p><p><span><strong>首例回眸 RDN疗效稳定</strong></span></p></section><section powered-by="xiumi.us"><section/></section></section></section><section powered-by="xiumi.us"><section><p>2021年4月16日，美敦力Symplicity Spyral™肾动脉交感神经多级射频消融导管在博鳌超级医院完成国内首例临床应用手术，一位来自上海的患者受益于这一国际领先的技术，获得了良好疗效。此次进博会现场，这位患者也受邀分享了术后一年的恢复状况。</p><p><img data-backh="368" data-backw="552" data-galleryid="" data-ratio="0.666875" data-s="300,640" data-src="https://mmbiz.qpic.cn/mmbiz_png/hfau27COcrDQOIZ697qSEbroxYo8kZwPicGKj7zADYnibUsDrakfQlJ2ZX66jEwY2hf7KHWgMlSAnsvTE0SJekfw/640?wx_fmt=png" data-type="png" data-w="1600" class="src" src="./../../static/load.gif"/></p><p>患者解释，自己因一次感冒意外确诊高血压，但并未认识到高血压的严重性，也未遵医嘱按时服药。由于血压长期未得到控制，逐渐造成了心脏损伤，由此也开始担心高血压未来对生活和家庭的影响。经过全方位评估，在去年4月来到博鳌，接受了RDN手术。<em><span><strong>整个手术非常顺利，术后无不良反应，也并未在体内留下任何器械。目前患者在不需要服用降压药物情况下，高压可以较好控制，且术后整体的精神状态、身体状况和心理状态较之以往也变得更好。</strong></span></em><span/></p><p>值得一提的是，为推动RDN疗法更好进入临床，美敦力付出了超过10年时光的努力，累积了大量的循证医学证据，包括多项随机对照研究验证 RDN 疗法在服用或未服用药物的高血压患者中的有效性、安全性与持久性<sup>1，2</sup>；以及一项全球最大规模的登记研究，验证其在真实世界中更广泛的适用性<sup>3</sup>。</p><p>目前该设备已于 2013 年获得欧盟认证并于 2020 年获得美国 FDA 突破性设备认证，目前已在全球 60 多个国家和地区上市。相信不久后，产品会正式进入中国临床，造福国内更多高血压患者。</p></section></section></section></section></section></section><section powered-by="xiumi.us"><section powered-by="xiumi.us"><section><section><section powered-by="xiumi.us"><section><section><section powered-by="xiumi.us"><section><section powered-by="xiumi.us"><section><section powered-by="xiumi.us"><section><section powered-by="xiumi.us"><section><section powered-by="xiumi.us"><section><section powered-by="xiumi.us"><p><span><strong><strong><span><strong>携手共进</strong></span></strong></strong></span></p><p><span><strong><strong><span><strong>中国高血压介入诊疗再迎新篇</strong></span></strong></strong></span></p></section><section powered-by="xiumi.us"><section/></section></section></section><section powered-by="xiumi.us"><section><section powered-by="xiumi.us"><section><p><img data-backh="277" data-backw="552" data-croporisrc="https://mmbiz.qpic.cn/mmbiz_jpg/hfau27COcrDQOIZ697qSEbroxYo8kZwPib0aeBa8h9Zr6a2V6KPYgKUsXYVX87jhMpWicE0MwP5UmsyYFApVk2hw/640?wx_fmt=jpeg" data-cropx1="0" data-cropx2="850" data-cropy1="140.1268115942029" data-cropy2="566.6666666666666" data-ratio="0.5023529411764706" data-s="300,640" data-src="https://mmbiz.qpic.cn/mmbiz_jpg/hfau27COcrDQOIZ697qSEbroxYo8kZwPQ2udgcZUxRl8UWLotRRwC1Wc7jFMwf5LEoe5BQZXlmgr74pYLbDcoQ/640?wx_fmt=jpeg" data-type="jpeg" data-w="850" class="src" src="./../../static/load.gif"/></p></section><section><span>在特邀嘉宾的见证下，高血压介入诊疗规范化项目（下文简称“项目”）拉开帷幕。</span></section><section><span><strong><span>霍勇教授、孙宁玲教授、陶嘉先生</span></strong></span><span>在接下来的致辞环节中向广大关心和支持我国高血压诊疗事业发展的同道和患者们表达了推动项目顺利开展的决心与信心。</span></section></section><section powered-by="xiumi.us"><section powered-by="xiumi.us"><section><section><section powered-by="xiumi.us"><section><p><span><strong>霍勇：落实三大“共建” 聚焦RDN疗法的规范化落地</strong></span></p></section></section><section powered-by="xiumi.us"><p><img data-backh="368" data-backw="552" data-ratio="0.66640625" data-s="300,640" data-src="https://mmbiz.qpic.cn/mmbiz_jpg/hfau27COcrDQOIZ697qSEbroxYo8kZwPhzujJgP31rff9hClianIiboBkwbWocQdtdtkV0aH6RHVgYial86GicRh9Q/640?wx_fmt=jpeg" data-type="jpeg" data-w="1280" class="src" src="./../../static/load.gif"/></p></section><section powered-by="xiumi.us"><section><p>“规范化落地需要政府、医疗机构、医疗工作者、学协会机构、企业单位等社会各界力量，去建立这个高血压介入治疗新疗法的‘规范化’流程。” <span><strong>霍勇教授</strong></span>表示，“在未来，心血管健康联盟将与美敦力，展开以下聚焦RDN疗法的规范化落地合作：一是建立高水平的高血压介入诊疗学术交流平台；二是推动RDN临床规范化应用医师培训；三是推动提升公众及患者对于高血压创新疗法认知。”</p><section><strong><span><em><span/></em></span></strong></section><p><span><strong>孙宁玲：规范化发展 着力提升高血压患者认知率</strong></span></p></section></section><section powered-by="xiumi.us"><p><img data-backh="368" data-backw="552" data-galleryid="" data-ratio="0.6666666666666666" data-s="300,640" data-src="https://mmbiz.qpic.cn/mmbiz_jpg/hfau27COcrDQOIZ697qSEbroxYo8kZwP9ljIm6WfclqpGXaE9AVQwAdzvN7o6nkzGj1jefNxWO2RnEZtSGzDNQ/640?wx_fmt=jpeg" data-type="jpeg" data-w="1080" class="src" src="./../../static/load.gif"/></p></section><section powered-by="xiumi.us"><section><section><span><strong>孙宁玲教授</strong></span>借着项目的契机分享了她对当前我国高血压疾病诊疗现状的看法。孙宁玲教授强调，现阶段提升高血压患者的认知是高血压治疗前期的重中之重，而创新的高血压介入方式与产品必将再次引起广大高血压患者对于疾病及其治疗流程的关注，从而实现这一目标。</section><section><em><span><strong>“<span>未来将更着眼于高血压患者的诊疗现状，明确高血压介入学科包括转诊、治疗和随访在内的规范化流程；服务于患者的就诊体验，期待能从全局角度提高患者的知晓率以及依从性。</span>”</strong></span></em></section><hr/><section><em><span/></em></section><section><section powered-by="xiumi.us"><section><section powered-by="xiumi.us"><section><img data-ratio="0.7497393" data-src="https://mmbiz.qpic.cn/mmbiz_jpg/hfau27COcrDQOIZ697qSEbroxYo8kZwPDJz9fjJ5xfatbDEOC3HIfnaRvp2rB4UE9Wq3NsamjDm47Shc9nrgpQ/640?wx_fmt=jpeg" data-type="jpeg" data-w="959" class="src" src="./../../static/load.gif"/></section></section></section><section><section powered-by="xiumi.us"><section><img data-ratio="0.7497393" data-src="https://mmbiz.qpic.cn/mmbiz_jpg/hfau27COcrDQOIZ697qSEbroxYo8kZwPIW4Ajc9VejFOY2AhtmSBkS9VNYTUFmIY1z8nIAtuic5wJYVkforic7xg/640?wx_fmt=jpeg" data-type="jpeg" data-w="959" class="src" src="./../../static/load.gif"/></section></section></section></section></section><p><span><strong>会后采访中，霍勇教授和孙宁玲教授进一步补充了项目的意义和RDN疗法对我国高血压疾病诊疗方式变革的展望。</strong></span></p><section>两位专家强调，直至今天我国高血压疾病的防治形势仍然严峻，高血压的治疗率、达标率和知晓率都有待提高。RDN疗法作为高血压介入治疗方式的一种，已经经历了十余年的发展完善，期积累了大量且丰富临床证据和循证数据，手术安全性和有效性已经有了肯定。此次美敦力与心血管健康联盟围绕RDN疗法规范化实践达成合作，也是一次新技术引领下改善我国高血压疾病诊疗与防治形势的新契机，希望RDN疗法随着项目的开展能切切实实地为高血压患者带来益处。</section><section><span><strong>陶嘉：支持科技医疗创新以造福患者的决心不改</strong></span></section><hr/><p><span><strong><img data-backh="368" data-backw="552" data-cropselx1="0" data-cropselx2="552" data-cropsely1="0" data-cropsely2="368" data-ratio="0.66640625" data-s="300,640" data-src="https://mmbiz.qpic.cn/mmbiz_jpg/hfau27COcrDQOIZ697qSEbroxYo8kZwPQgB0XgLEwh0IxDUqLgFSLICRV3MIEOLFeafF9wbWq04UeZVDSvCsibA/640?wx_fmt=jpeg" data-type="png" data-w="1280" class="src" src="./../../static/load.gif"/></strong></span></p><section><span><strong>陶嘉先生</strong></span>介绍，美敦力自 2009 年起，就从未停止过对高血压微创介入治疗技术的探索和突破，这也是我们助力于优化高血压这类慢性疾病解决方案的决心。而心血管健康联盟作为行业内领先的学术组织，多年来专注于临床医护人员专业能力地综合提升以及患者对于疾病地教育工作，尤其是高血压达标中心的建设工作，也进一步提升了规范高血压的诊疗和管理，以最大限度地降低心血管发病和死亡的总危险。</section><section><span><strong><em>“这与美敦力不断支持科技医疗创新以造福患者的决心是不谋而合地。<span>”</span></em></strong></span></section><p>立足RDN疗法的未来发展，<span><strong>陶嘉先生</strong></span>在接受采访时踌躇满志。</p><section>他介绍，美敦力与心血管健康联盟的合作始于2017年，此次借助RDN疗法上市前在进博会上展示的契机，以联盟所倡导的高血压达标中心为合作框架，再次建立新合作，必将更好的助力于加强高血压的规范化诊疗水平，推动高血压达标中心建设，为实现健康中国 2030 而努力！ </section><section><strong>顾宇韶：用循证推动新疗法发展</strong></section><p><img data-backh="368" data-backw="552" data-ratio="0.66640625" data-s="300,640" data-src="https://mmbiz.qpic.cn/mmbiz_jpg/hfau27COcrDQOIZ697qSEbroxYo8kZwP6oWSqzTn3gWCLlRHJ58qH5TLzUx71aeslomurNjkgnDeITSJWJolsA/640?wx_fmt=jpeg" data-type="jpeg" data-w="1280" class="src" src="./../../static/load.gif"/></p><p><span><strong>顾宇韶先生</strong></span>在媒体采访环节同样也表达了美敦力推动中国高血压诊疗创新管理模式发展的企业愿景，表示美敦力一如既往通过开创性疗法的研发造福更多患者，例如中国庞大的高血压患者。基于为病患和临床的提供更高标准的解决方案，每一次疗法的创新和开发都需要时间和数据来验证疗法的有效性和安全性，即便是在过程中遇到挑战。</p><p><em><span><strong>“</strong></span></em><span><em><strong><span><span>同时，我们也希望看到有更多的企业关注到创新疗法，并参与到前期的临床验证阶段，共同推动创新疗法更快的落地。</span></span></strong></em></span><em><span><strong>”</strong></span></em></p><section><span><strong><em><span/></em></strong></span></section></section></section></section></section></section></section></section></section></section></section></section><section><strong><span><strong> </strong></span></strong><strong><span><strong/></span></strong></section></section></section></section></section></section></section></section></section></section></section></section></section><section powered-by="xiumi.us"><section><section powered-by="xiumi.us"><section><section powered-by="xiumi.us"><section><section powered-by="xiumi.us"><section><section powered-by="xiumi.us"><p><br/></p><p><span><strong><span>四度亮相 RDN展台精彩纷呈</span></strong></span></p></section><section powered-by="xiumi.us"><section/></section></section></section><section powered-by="xiumi.us"><section><section powered-by="xiumi.us"><section><section powered-by="xiumi.us"><section><span>作为连续四年参加进博会的医疗创新设备之一，美敦力每年都在尝试用多元形式或途径让更多参与进博会的专业医生和其它参会嘉宾能深度了解RDN疗法。</span></section><section><span><img data-backh="368" data-backw="552" data-ratio="0.66640625" data-s="300,640" data-src="https://mmbiz.qpic.cn/mmbiz_jpg/hfau27COcrDQOIZ697qSEbroxYo8kZwPVlCLd2sKiaVibesSq8g0QPQT46G2OYtib90icmKWbx4UE4HzYn1Hxqob4Q/640?wx_fmt=jpeg" data-type="jpeg" data-w="1280" class="src" src="./../../static/load.gif"/></span></section><section><span><img data-backh="368" data-backw="552" data-ratio="0.66640625" data-s="300,640" data-src="https://mmbiz.qpic.cn/mmbiz_jpg/hfau27COcrDQOIZ697qSEbroxYo8kZwPmibgUhpicNwwz6CicwgasHLica5QX5rkFFsN8ooX6O5AQeD639ce7p7pFQ/640?wx_fmt=jpeg" data-type="jpeg" data-w="1280" class="src" src="./../../static/load.gif"/></span></section></section></section></section><section powered-by="xiumi.us"><section><section><span/>此次进博会上，美敦力特别设置高血压介入疗法的体验环节，借助模拟器邀请现场嘉宾们参与到创新高血压介入疗法的体验中，营造了一种沉浸式的互动体验形式，以此集中展示产品在临床场景中的操作和创新优势。</section><section><em><span/></em><span><strong><span/></strong></span></section></section></section></section></section></section></section></section></section></section></section><section powered-by="xiumi.us"><section powered-by="xiumi.us"><section><section><section powered-by="xiumi.us"><section><section><section powered-by="xiumi.us"><section><section powered-by="xiumi.us"><section><section><section powered-by="xiumi.us"><section><section powered-by="xiumi.us"><section><section powered-by="xiumi.us"><section><section><section powered-by="xiumi.us"><section><section powered-by="xiumi.us"><section><section powered-by="xiumi.us"><section><section powered-by="xiumi.us"><p><br/></p></section></section></section></section><section><section powered-by="xiumi.us"><section><section powered-by="xiumi.us"><p><br/></p></section></section></section></section><section><section powered-by="xiumi.us"><section><section powered-by="xiumi.us"><p><br/></p></section></section></section></section></section></section></section><section powered-by="xiumi.us"><section><section powered-by="xiumi.us"><p><span><strong>长久以来，临床医生们上下求索，期待新降压方法的出现，实现更长久、轻松的降压。RDN疗法经历十多年的发展走到临床，打破了患者只能依赖药物降压的困境；美敦力也以坚实有力的循证医学证据证明了RDN疗法能实现长久、轻松降压的可能。</strong></span></p><section><span><strong>而新生的诊疗技术如何健康发展、规范应用、为数以亿计的高血压患者带来了长期、稳定控制血压的新希望，考验着临床医生们的勇气和智慧。</strong></span></section><section><span><strong>在RDN疗法旭日初升之时，高血压介入诊疗规范化项目顺势而生，以此为切口，美敦力携手中国临床医生，必将在项目运行过程中务实前沿理念，助力RDN技术规范化发展，推动我国高血压诊治事业迈步新篇章！</strong></span></section></section></section></section></section><section><span/></section></section></section></section></section></section></section></section><section><strong><span/></strong></section></section></section></section></section></section></section></section></section></section></section></section><section powered-by="xiumi.us"><section><section powered-by="xiumi.us"><section><section powered-by="xiumi.us"><section><p><strong>参考文献：</strong></p></section></section><section powered-by="xiumi.us"><section><p>[1] Townsend R R, Mahfoud F, Kandzari D E, et al. Catheter-based renal denervation in patients with uncontrolled hypertension in the absence of antihypertensive medications (SPYRAL HTN-OFF MED): a randomised, sham-controlled, proof-of-concept trial[J]. The Lancet, 2017, 390(10108): 2160-2170.</p><p>[2] Mahfoud F, Kandzari D E, Kario K, et al. Long-term efficacy and safety of renal denervation in the presence of antihypertensive drugs (SPYRAL HTN-ON MED): a randomised, sham-controlled trial[J]. The Lancet, 2022, 399(10333): 1401-1410.</p><p>[3] Mahfoud F, Mancia G, Schmieder R, et al. Renal denervation in high-risk patients with hypertension[J]. Journal of the American College of Cardiology, 2020, 75(23): 2879-2888.</p></section></section></section></section></section><section><section powered-by="xiumi.us"><section><section powered-by="xiumi.us"><section><section powered-by="xiumi.us"><section><p><span>· END ·</span></p><p><span>本文内容为“严道医声”发布</span></p><p><span>转载发布须经授权并注明出处</span></p></section></section></section></section><section powered-by="xiumi.us"><section><section powered-by="xiumi.us"><section><img data-ratio="0.7" data-src="https://mmbiz.qpic.cn/mmbiz_png/hfau27COcrDQOIZ697qSEbroxYo8kZwPeeFEfqgM79Xk0yVXzCz92Rp3RQWDYH1Xf3ibEhVlI8vhhljExct4Igg/640?wx_fmt=png" data-type="png" data-w="1000" class="src" src="./../../static/load.gif"/></section></section></section></section><section powered-by="xiumi.us"><section><section powered-by="xiumi.us"><section><p>获取更多资讯，点击 <span>“阅读原文”</span> 下载 <strong><span>“严道医声APP”</span></strong><span/></p></section></section></section></section></section></section></section></section></section></section></section><p><mp-style-type data-value="3"/></p> 
        
         </article>
   <script type="text/javascript" src="./../../nav/jquery.lazyload.src.js"></script>
   <script type="text/javascript" charset="utf-8">
  $(function() {
      $("img.src").lazyload({ placeholder : "./../../static/load.gif",effect: "fadeIn"});
  });
</script>

    </div>
</main>



    <div class="footer" style="background-color: #ced3d6">

            <div class="w80 juzhong">
                <img class="wybf" src="./../../upload/images/footzhuban.png" style="width: 100%;z-index:99">
              <img class="sjbf" src="./../../upload/images/footzhuban1.png" style="width: 100%;z-index:99">
                    <p class="wybf" style="color: black" class="footer-copytxt">COPYRIGHT <a href="https://beian.miit.gov.cn/"  target="_blank">沪ICP备16029818号-3</a> GBAIE Co., Ltd. All right reserved  <br/>备案号：<a href="http://beian.miit.gov.cn/" target="_blank"><span style="color:black">沪ICP备16029818号-3</span></a>
                    </p>
                    <p class="sjbf" style="color: black;padding-top: 30px;text-align: center;clear: both;width: 90%;padding-left: 30px;" class="footer-copytxt"><a href="https://beian.miit.gov.cn/"  target="_blank">沪ICP备16029818号-3</a> COPYRIGHT <a href="https://beian.miit.gov.cn/"  target="_blank">沪ICP备16029818号-3</a> GBAIE Co., Ltd. All right reserved <br>
                    </p>
            </div>
	</div> 
    
    
<!-- 实现PC端右侧界面侧边栏 -->
    <ul id="scrollSearchDiv" class="rightline wybf" >
    <!--二维码图片div-->
        <li class="li2" ></li>
        <li class="li1" ></li>
        <div class="flex wybf"></div>
    <style type="text/css">
    	.li4::before {
          content:'\e612';
          font-size: 27px;
    	}
    </style>

        <div class="flex1 wybf">

        </div>
        <!--<li class="li4"></li>
        <div class="flex2 wybf"></div>-->
        <li class="li5"></li>
    </ul>
</body>
</html>